Transplantation Topic Homepage

Anti-Infectives Knowledge Network IFI

,AIKN IFI

The Anti-infectives Knowledge Network – Invasive Fungal Infections (AIKN-IFI), an initiative by Astellas Pharma EMEA, shares the expertise and experience of a number of thought leaders in the disease therapy area of Anti-infectives.

Most recent updates with content from the 20th Annual International Liver Transplantation Society (ILTS) Congress which included an interactive case discussion presented by Carlos Cervera - 'Focus on candidaemia'.

News reports and sponsored presentations from this year: ECCMID, EBMT, ASM, ISICEM, AAA.

Also available - Free downloadable ESCMID Guidelines Supplement for the diagnosis and management of Candida diseases and related slides for use in your own presentations.

Please remember to return regularly to read the news, clinical insights, and essential information from the latest congresses.

Click here to enter the AIKN-IFI

Anti-Infectives Knowledge Network CDI

,AIKN CDI

The Anti-infectives Knowledge Network – Clostridium difficile Infections (AIKN-CDI), an initiative by Astellas Pharma EMEA Ltd., shares the expertise and experience of a number of thought leaders in the disease therapy area of Anti-infectives.

Most recent updated with content from ID Week 2014, these reports detail the national estimates of CDI incidence in the USA, how to predict the risk of CDI and the burden that recurrent CDI brings to healthcare settings.  

News reports and sponsored presentations from this year: ICAAC ECCMID, EBMT, and ISICEM.

Also available – Interative annotated treatment guidelines for the management of Clostridium difficile infection.

Please remember to return regularly to read the news, clinical insights, and essential information from the latest CDI congresses.

Click here to enter the AIKN-CDI.

Blog

Would you trust a doctor to decide if you are an appropriate subject for assisted dying? I wouldn't, neither should you, and my colleagues who are not fortunate enough to be retired will be crazy if they allow themselves to be dragged into the process. Proponents of legislative change should man up and face the implications of their proposals, without hiding behind the medical profession.

Medical Videos

An Overview of Blood Transfusions
An Overview of Blood Transfusions
Corneal Transplant - The Diseases, Procedures and Success Rates
Corneal Transplant - The Diseases, Procedures and Success Rates
Heart Transplantation - The Reasons for Transplantation and the Success Rates
Heart Transplantation - The Reasons for Transplantation and the Success Rates
Lung Transplants - The Benefits and Limitations
Lung Transplants - The Benefits and Limitations

Recent Drug Updates

Medical Journal Abstracts on Transplantation

Living vs. Deceased Donor Liver Transplantation Provides Comparable Recovery of Renal Function in Patients With Hepatorenal Syndrome: A Matched Case–Control Study

Thu 02 Oct 2014 -  American Journal of Transplantation

Outcomes of living versus deceased donor liver transplantation in patients with chronic liver disease and hepatorenal syndrome (HRS) was compared using a matched pair study design. Thirty patients ...

Analysis of factors affecting immune recovery and initial response to tetanus after DTaP vaccination in pediatric allogeneic HSCT patients

Sun 21 Sep 2014 -  Pediatric Transplantation

Transfer of donor immunity after allo-HSCT is limited, requiring re-vaccination after HSCT. The CDC 2009 guidelines introduced earlier vaccination post-HSCT with a uniform vaccination strategy. This ...

Clinical Guidelines

Management of cytomegalovirus infection in haemopoietic stem cell transplantation

May 2013

These evidence-based guidelines expand and adapt previous guidance (Tomblyn et al, 2009; Andrews et..

... al, 2011). While specifically focusing on allogeneic haemopoietic stem cell transplantation (HSCT), they are relevant to other areas of haematological oncology where there is an increased risk of cytomegalovirus (CMV) infection, such as haematological cancers where intense anti-T-cell therapy has been deployed (O’Brien et al, 2006).

ESCMID guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)

Dec 2012

Fungal diseases still play a major role in morbidity and mortality in patients with haematological..

... malignancies, including those undergoing haematopoietic stem cell transplantation. Although Aspergillus and other filamentous fungal diseases remain a major concern, Candida infections are still a major cause of mortality. This part of the ESCMID guidelines focuses on this patient population and reviews pertaining to prophylaxis, empirical/pre-emptive and targeted therapy of Candida diseases. AntiCandida prophylaxis is only recommended for patients receiving allogeneic stem cell transplantation.

Clinical Trials

Effectiveness of an APN-led Self-management Program in Patients in the First Year After Renal Transplantation (SMP-NEP)

27-10-2014

The aim of this study is to investigate the effectiveness of the program in patients after renal transplantation using a randomized controlled trial design. Physical, behavioural, and clinical outcomes will be measured at baseline before randomization then 8 and 12 months later.

Attitudes About Organ Transplantation (KAPsurvey)

26-10-2014

The study evaluates the knowledge, attitude and practice about organ transplantation among medical students and medical staff.

Back to top